[Asia Economy Reporter Hyunseok Yoo] Medical device specialist Hubexel announced on the 2nd that it has obtained two patents for its ‘intervertebral fusion fixation device’ and ‘detachable intervertebral fusion fixation device’.


The patents cover products designed to facilitate fusion surgery by inserting fixation screws into interbody fusion implants used in anterior cervical fusion surgery, which is the standard treatment for cervical spine diseases.


Cervical disc surgery involves making a horizontal incision on the front of the neck to remove the intervertebral disc and inserting artificial bone or a cage to firmly fix the vertebrae, a method known as ‘anterior cervical fusion surgery’.


Anterior cervical fusion surgery is considered the standard for cervical spine operations. The patents are for cages used in this cervical disc surgery that are designed to allow the insertion of fixation screws. This design enhances fixation strength so that the cage can be used alone, significantly reducing procedure time compared to traditional surgeries that require both a cage and a plate.



A company representative stated, "Domestic regulatory approval is already underway and is expected to be completed this month. With the expansion of the product lineup for procedures used in cervical spine diseases, an increase in domestic sales is anticipated. We have already received orders for the patented products from South Africa and the UAE, and once domestic approval is completed, we plan to proceed with exports."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing